https://clinicaltrials.gov/ct2/show/NCT03451422?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F03%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Interventions : Drug: AMG 592; Drug: Placebo
Sponsor : Amgen
Recruiting
Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus
NCT03451422
Thu, 01 Mar 2018 12:00:00 EST
